alpha 2C adrenoceptor agonists (Merck)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha 2C adrenoceptor agonists (Merck)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-2c adrenergic receptor agonists
TargetsAlpha-2c adrenergic receptor
Therapy Area/IndicationsNeuralgiaNasal Obstruction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Research Laboratories
Active IndicationsN/A
Inactive IndicationsNeuralgiaNasal Obstruction

Other Information

ATC CodeN/A
Related LinksN/A